Abstract
Background Literature shows that patients with obesity and Obstructive Sleep Apnea (OSA), both occurring independently, are more likely to develop cardiovascular diseases and sudden cardiac death (SCD). Assuming that ventricular depolarization is more stable than repolarization then QT interval parameters may be used for heart muscle repolarization assessment for those groups of patients.
Methods There were 121 patients included in the study, both – women and men, aging from 35-65 with visceral obesity. Only healthy patients were included – the ones who were not treated for any chronic disease, taking QT elongating drugs, or were not treated with Continuous Positive Airway Pressure (CPAP) therapy at that time.
Results OSA was diagnosed in 70 patients (including 41 male). A statistically significant difference for QT interval parameters between OSA positive and negative patients was found (p<0.001 for all variables). No difference for QTc max or for QT interval parameters between groups of patients with different OSA severity degrees was found. A correlation between QTVi2 and QTVi3 (p=0.008) and between polygraphy specific parameters and QTc max, QTVi2 and QTVi3 was found.
Conclusions OSA has a negative influence on heart muscle repolarization processes by increasing QTV and QTVi values, without such an impact on QTc max interval among patients with visceral obesity. A temporary intensification of OSA causes additional increase of QTVi value. OSA severity degree expressed by specific parameters taken from polygraphic examination prolongs QTc max and increases QTV and QTVi values.
What is the key question?
Does Obstructive Sleep Apnea destabilize heart muscle repolarization time heterogeneity expressed by QT interval assessment parameters (QTc, QTV, QTVi)?
What is the bottom line?
Obstructive Sleep Apnea occurrence presents an essential negative influence on heart muscle repolarization time, as heterogeneity by QTV and QTVi values increase, while QTc max interval remains unaffected among patients with visceral obesity.
Why to read on?
Knowing that obesity and Obstructive Sleep Apnea (occurring separately) increase the risk of sudden cardiac death, cardiovascular risk evaluation becomes an important point for obese, OSA positive patient’s care.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Bioethical commission of the Medical University of Warsaw, Poland
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Participants' enrollment to the clinical trial had begun in September 2016 and had finished in August 2019.
